E2F1 and ovarian carcinoma: Its role in ovarian cancer has been unclear, as other research groups have found similar favourable survival with increased E2F1 pathway activation [32], while other findings have shown favourable survival with decreased E2F1 gene expression by RT-PCR [33], [34].